Early Onset Marfan Syndrome with multivalvular insufficiency: Report from a tertiary hospital in Tanzania, and a review of the recurrent c.7606G>A p.0 variant in FBN1

Eur J Med Genet. 2022 Nov;65(11):104576. doi: 10.1016/j.ejmg.2022.104576. Epub 2022 Sep 2.

Abstract

Marfan Syndrome is an autosomal dominant connective tissue disorder caused by mutations in the FBN1 gene. Early Onset Marfan Syndrome is at the severe end of the Marfan syndrome spectrum and is frequently associated with variants in exons 24-32 of the FBN1 gene. To the best of our knowledge, this is the first molecularly confirmed patient from Sub-Saharan Africa with Early Onset Marfan Syndrome who presented with tall stature, arachnodactyly, multivalvular insufficiency and ectopia lentis. Sequencing analysis of FBN1 gene revealed a pathogenic (class 5) heterozygous recurrent variant in exon 61 (c.7606G > A p.0NM_000138.3), which was up to now not associated with rapidly progressive Marfan syndrome with multivalvular insufficiency and congestive cardiac failure. This further supports the notion that the interplay of the given FBN1 mutation, one or more genetic modifiers and epigenetic and environmental factors defines the disease phenotype.

Keywords: Early Onset Marfan syndrome; Heterozygous recurrent exon 61 FBN1 variant; Multivalvular insufficiency; Sub-Saharan Africa; Tanzania.

Publication types

  • Review

MeSH terms

  • Ectopia Lentis* / genetics
  • Fibrillin-1 / genetics
  • Fibrillins / genetics
  • Humans
  • Marfan Syndrome* / genetics
  • Mutation
  • Tanzania
  • Tertiary Care Centers

Substances

  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins